© 2020 MJH Life Sciences and OncLive. All rights reserved.
June 12, 2020
Joshua Brody, MD, discusses Fas and its impact on bystander killing in patients with non-Hodgkin lymphoma.
May 28, 2020
Joshua Brody, MD, discusses addressing required resistance to immunotherapy in non-Hodgkin lymphoma.
April 22, 2020
Joshua Brody, MD, discusses the role of immunotherapy in indolent lymphomas.
April 16, 2020
Joshua Brody, MD, discusses the utility of in-situ vaccines as a novel way to harness immune response and extend the reach of immunotherapy in patients with advanced-stage indolent non-Hodgkin lymphoma.